CLINICAL TRIALS PROFILE FOR CURRETAB
✉ Email this page to a colleague
All Clinical Trials for CURRETAB
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00064025 ↗ | Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus | Completed | National Cancer Institute (NCI) | Phase 2 | 2004-04-01 | This phase II trial is studying how well medroxyprogesterone works in treating patients with endometrioid adenocarcinoma (cancer) of the uterine corpus (the body of the uterus, not including the cervix). Hormone therapy using medroxyprogesterone may be effective in treating endometrioid cancer. |
NCT00064025 ↗ | Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus | Completed | Gynecologic Oncology Group | Phase 2 | 2004-04-01 | This phase II trial is studying how well medroxyprogesterone works in treating patients with endometrioid adenocarcinoma (cancer) of the uterine corpus (the body of the uterus, not including the cervix). Hormone therapy using medroxyprogesterone may be effective in treating endometrioid cancer. |
NCT00577122 ↗ | Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer | Completed | Translational Breast Cancer Research Consortium | Phase 2 | 2007-07-01 | The purpose of this study is to evaluate the impact of MPA alone and in combination with low dose oral chemotherapy in patients with ER- and PR- advanced breast cancer. |
NCT00577122 ↗ | Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer | Completed | Indiana University | Phase 2 | 2007-07-01 | The purpose of this study is to evaluate the impact of MPA alone and in combination with low dose oral chemotherapy in patients with ER- and PR- advanced breast cancer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CURRETAB
Condition Name
Condition Name for CURRETAB | |
Intervention | Trials |
Estrogen Receptor-negative Breast Cancer | 1 |
Progesterone Receptor-negative Breast Cancer | 1 |
Recurrent Breast Cancer | 1 |
Recurrent Uterine Corpus Carcinoma | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for CURRETAB
Trials by Country
Clinical Trial Progress for CURRETAB
Clinical Trial Phase
Clinical Trial Sponsors for CURRETAB
Sponsor Name